Health ❯ Healthcare ❯ Cancer Research

Clinical Trials

Patient Outcomes Preclinical Studies Drug Development Targeted Therapy Therapeutic Innovations Survival Rates Dietary Interventions Bispecific CAR T Cells Aspirin Treatment NHS Galleri Trial

Engineered CAR T Cells Targeting MUC16 Control Bladder Tumors in Mice

Direct catheter delivery confined the engineered cells to the bladder, thereby reducing off-target spread, paving the way for clinical testing.

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

Penn Study Finds About 30% Lower Breast Cancer Incidence Among Women Prescribed GLP‑1 Drugs

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

Experimental KRAS Drug Nearly Doubles Survival in Advanced Pancreatic Cancer

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

International Panel Backs Fast MRI, Risk-Based Pathways for Prostate Cancer Screening

NHS England Launches National Inherited Cancer Risk Register to Drive Targeted Screening

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

Swedish Study Ties Lower Ipilimumab Dose to Longer Survival and Less Toxicity in Advanced Melanoma

ECOG-ACRIN Review Finds Black AML Patients Have Worse Survival Independent of Cytogenetics

AACR Releases First Pediatric Cancer Progress Report, Citing Record Survival and Persistent Gaps

Two Nature Studies Show FSP1 Blockade Triggers Ferroptosis and Shrinks Tumors in Mice

Targeted Nanoparticles Help Checkpoint Drugs Erase Ovarian Tumors in Mice

mRNA Covid Vaccination Linked to Longer Survival When Given Near Cancer Immunotherapy, Nature Study Finds

Galleri Multi-Cancer Blood Test Posts 61.6% PPV and 99.6% Specificity in Pathfinder 2

Lobular Breast Cancer Is Rising Fast, Now Over 1 in 10 U.S. Cases

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

Maharashtra Approves Cancer Care Policy, Launches MAHACARE Foundation

UCLH Becomes First NHS Trust to Offer ROCA Surveillance for BRCA-Linked Ovarian Cancer